JSB Market Research: Global and USA Cancer Biomarker Market to 2018

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 280 tables & figures over 232 pages. The oncology biomarker (globaland USA) market is presented as follows:

By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD, FOUNDATION MEDICINE, GENOMIC HEALTH)
By Geography (Global, US)
By Sub-market (Global Biomarker Market, Cancer Biomarker Market, Global Cancer Profiling Technology Market )

Browse Full Report @ http://www.jsbmarketresearch.com/healthcare-medical/r-GLOBAL-USA-CANCER-BIOMARKER-MARKET-115008

A wealth of financial data & business strategy information is provided including:

Up-to-date company financials, sales & revenue figures
Revenue and market forecasts up to 2018
Business model strategies for diagnostic, pharmaceutical and biotechnology companies
Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations)
Comprehensive account of company product financials, portfolios & kits

SWOT, Economic & Regulatory Environment specifics include:

Key strengths, weaknesses and threats influencing leading player position within the market
Technologies driving the market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)
Top fastest growing market segments and emerging opportunities
Top pharmaceutical companies within the cancer biomarker market
Comprehensive product portfolios, R&D activity and pipeline therapeutics
M&A activity and future strategies of top companies
Approved biomarker companion diagnostic tests
High demand and Unmet Need Enhances the Global Biomarker Market
FDA Support Increases Biomarker Development
More Streamlined Clinical Trials
Significant Growth of High-Impact Oncogenic Biomarker Research
Advancements in Discovery Technologies
Challenges of the Oncogenic Biomarker Market
Variability of Biomarkers within Different Cancer Subtypes
Integration of Genomics and Biomarker Diagnostics into the Healthcare System
Ethical Considerations

The "GLOBAL and USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)" report highlights a number of significant Indian pharmacos and gives details of their operations, products, financials and business strategy.

23andMe
Affymetrix
Ambry Genetics
Astex Pharmaceuticals
Atossa Genetics
BioMerieux
CuraGen
Celera Corporation (Quest Diagnostics)
Celldex Therapeutics
deCode Genetics (Amgen)
Foundation Medicine
Illumina
Genelex
Genomic Health
Myriad
Nodality
OriGene Technologies
Randox
Qiagen
 

Table Of Content :

1.0 Executive Summary 13
1.1 Objectives of Report 13
1.2 Data Sources and Methodology 15
1.3 Key Findings and Observations 15
1.3.1 What Makes Cancer Biomarkers so Important for the Healthcare Industry? 15
1.3.2 What Technologies are Used to Identify Novel Biomarkers? 16
1.3.3 Increase in Cancer Prevalence is Propelling the Oncogenic Biomarker Market 16
1.3.4 Global and US Economic Impact of Cancer 16
1.3.5 How Cancer Biomarkers are Revolutionizing Cancer Treatment 17
1.3.6 What are the most Significant and Strategic Cancer Biomarkers? 17
1.3.7 Global Biomarker Test Market Analysis 18
1.3.8 Global Cancer Biomarker Market Analysis 18
1.3.9 Oncology Biomarker Market Main Industry Players 19
1.3.10 Drivers, Restraints, Opportunities and Challenges of the Cancer Biomarker Market 19

2.0 Global Burden of Cancer 20
2.1 Global Cancer Statistics 20
2.2 Lung Cancer Globally 25
2.3 Lung Cancer Mutation Analysis 28
2.4 Colorectal (Bowel) Cancer Globally 29
2.5 Prostate Cancer Globally 31
2.6 Breast Cancer Globally 33
2.7 Global Economic Impact of Cancer 39
2.8 Cancer in the USA 40
2.9 Breast Cancer in the US 43
2.10 Lung Cancer in the US 44
2.11 Colorectal Cancer in the US 45
2.12 Prostate Cancer in the US 50
2.13 Skin Cancer in the US 52

3.0 Oncogenic Biomarkers An Overview 54
3.1 Biomarker Discovery to Clinical Validation 56
3.2 Specific Technologies Used in Biomarker Discovery 57
3.2.1 Proteomics 57
3.2.2 Mass Spectrometry Based Technologies 57
3.2.3 Principles of Diagnostic Mass Spectrometry 58
3.2.4 Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) 58
3.2.5 Nano LC-MS/MS 59
3.2.6 MALDI-TOF 59
3.3 Glycomics 60
3.4 Metabolomics 61
3.5 Peptidomics 62
3.5.1 Enzyme-Linked Immunosorbent Assay (ELISA) 62
3.6 Selected (Multiple) Reaction Monitoring 66
3.7 DNA Based Techniques 67
3.7.1 Microarrays 67
3.7.2 Small Molecule Real Time (SMRT) DNA Sequencing 69
3.7.3 Digital PCR 69
3.7.4 Next Generation Sequencing 70
3.7.5 Second-Generation Sequencing Platforms 71
3.7.6 Whole Genome Sequencing 71
3.7.7 Epigenomics 72
3.7.8 Bioinformatics and Next Generation Sequencing 72
3.7.9 Third Generation Sequencing 72

For More Related Market Research Reports click here:

Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019

Gastric Motility Disorder - Pipeline Review, H2 2014

About JSB Market Research -

JSB Market Research is one of the most significant databases of online market researches and intelligence reports and services. We specialize in providing market research reports for various industries. The online portal for marketing research deals with access to global market data and assists in providing expert insights and exposure on global companies, industries, products and trends.

Contact –

Tel: + 91 - 22 – 41236650

Website: http://www.jsbmarketresearch.com

Email - contact@jsbmarketresearch.com

Blog: http://www.jsbmarketresearch.com/blog/